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Medical technology is developing at an accelerated
rate. Advances and refinement in techniques of
electronic fetal heart rate (FHR) monitoring are
continually being designed and tested. Many of
these show real promise for the future. Never-the-
less, for the next several years there are two major
considerations. First, a more universal application
of FHR monitoring i.e., to the "normal" patient äs
well äs "high risk" and second, enhance educatiön in
FHR pattern recognition and proper management res-
,ponses.
Perinatal mortality is approximately equally diveded
between fetal and neonatal. Of the fetal mortality
only about 1/5 occurs intrapartum and the other 4/5
occurs antepartum. Application of FHR monitoring
during the antepartum period in an attempt to
identify the "at risk" fetus has received wide
acceptance. Of the two most commonly utilized
techniques i.e., contraction stress test (CST) (1)
and non-stress test (NST) ( 2 ) , the NST has the
advantage of being less time consuming and less
expensive. The simplicity of the NST, the immediate
availability of the results and the reliability of
the reactive test seems to make it an excellent
antepartum screening tool. A simple antepartum ·
testing tool such äs this that can have very wide
application is essential, since approximately one
half of all perinatal mortality occurs in "low risk"
pregnancies.
Schifrin et al (2) performed NST's .in 4517 "low" and
"high risk" patients. The perinatal mortality was
much lower in the reactive fetus of a "high risk"
mother (11/1000) than the non-reactive fetus of a
"low risk" mother (45/1000). Figure I
Vinacur (3) reported his experience in utilizing
routine NST's in private practice. In 208 consecutive
singleton pregnancies he found that no neonate was
in the .'ttiigh risk" category when the mother was
"low risk" and the NST was reactive. Non-reactive
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NST in a nlow risk11 pregnancy resulted in 2/7 "high
risk11 neonatal conditions. The highest risk group
was the "high risk" mother and a non-reactive NST.
Six to nine neonates in the "high risk" category.
Antepartum testing allows for individualization of
care since the fetus at greatest risk can be identi-
fied. This individualization not only benefits the
fetus at increased risk but all the other pregnancies
by allowing a policy of non-intervention based on the
individualization. In the future the trend appears
to be toward more universal application of antepartum
FHR testing.
Intrapartum FHR monitoring, especially in the 1000
to 15000 gram infant has been shown to result in
improved perinatal survival ( 4 ) . Paul et al reviewed
the obstetrical experience at LAC/USC Medical Center
from 1970-1975. In infants weighing 1500 grams,
intrapartum deaths occured less often in the "high
risk" monitored fetus than the "low risk" unmonitored
fetus. (Table I) Only four prospective, controlled
studies on intrapartum fetal monitoring have been
reported in the literature. ( 5 , 6 , 7 , 8 ) The total
number of patients in these studies is 2026. Schifrin
(9) calculated that in order to show a significant
reduction in perinatal mortality i.e., from 10/000
to 5/1000 one must have more than 4600 patients.
One of the strongest arguments for elective intra-
partum FHR monitoring of all patients is that we are
unable to identify all of the "high risk" fetal
situations even at the onset of labor. If one wanted
to monitor only the "high risk" fetus an accurate
selection would be impossible since many "high risk"
situations do not declare themselves until the time
of delivery. Hobel (10) utilized a risk scoring
.System during pregnancy with reassessment during labor.
He found that the mortality was greater in a "low
risk" pregnancy with a "high risk" intrapartum
Situation than in a "high risk" pregnancy with a "low
risk" intrapartum performance. Those who remained in
the "low risk" group in both assessments had a very
low perinatal mortality. Sokol (11) reported that
40% of women with "low risk" antepartum assessment
according to Hobel's scale, developed an intrapartum
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risk factor which carried increased risk of perinatal
mortality.
A major concern in the utilization of electronic FHR
monitoring in the "low risk" pregnancy is_that it
will result in an increased cesarean section rate.
Two recently reported studies of elective FHR
monitoring in "low risk" pregnancies did not confirm
these fears. Krebs (12) reported a 3% primary
cesarean section rate in 919 "low risk" monitored
labors. Westgren et al (13) monitored 4278 "low
risk" patients and performed a cesarean section for
fetal distress in only 30 patients.
TABLE I
Intrapartum deaths in weight 1500 g (at LAC/USC 1970-
1975) occur less often in monitored patients.
Patients with severe congenital anomalies and birth
trauma assoicated with death are eliminated from
both groups.
Intrapartum fetal deaths
High risk Low risk
Monitored unmonitored
Total patients 17,089 43,524
Fetal deaths 7 36
Rate per 1,000 0.4 0.8
x
2
=3.01, p 0.1
Reproduced with permission.
Paul, R . H . , Gauthier, R.J. and Quilligan, E.J. :
Clinical Fetal Monitoring. The usage and relation-
ship to trends in cesarean delivery and perinatal
mortality. Acta Obstet Gynecol Scanda.. 59: 289-
295, 1980.
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Figure I
Perinatal mortality in high and low risk pregnancies
who had antepartum non-stress testing. Adapted with
permission from: Schifrin, B.S. et al.: Obstet
Gynecol 54; 21, 1979.
Interpretation of FHR patterns and the diagnosis of
fetal distress are areas in which education and
experience play a very important role. In most
clinical situations, the introduction of elective
FHR monitoring results in an increased diagnosis of
fetal distress and subsequent cesarean deliveries.
With continued experience this rate usually levels
off or declines. Haddad and Lundy (14) review the
cesarean section rate in their hospital over a four
year period (1972-1975). One of their conclusions
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from this review was: "Close retrospective evaluation
of the definition for fetal distress on the monitor
tracing would suggest that only half (ö f ) these
patients should have required primary cesarean section
for the management of fetal distress". A better
understanding of the significance of FHR patterns
should lead tq a reduction in the cesarean section
rate for fetal distress.
It is inevitable that techniques will be developed
that will lead to improved use of electronic fetal
monitoring. Other techniques such äs ultrasound in
combination with EFM will improve the accuracy of
fetal evaluation. For the., near future however, a
better understanding of the pathophysiology of FHR
and greater utilization both antepartum and intra-
partum should enhance perinatal outcome.
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